AChild - Austrian Children With Hearing Impairment - Longitudinal Database

March 29, 2022 updated by: Johannes Kepler University of Linz

There is high variability in outcomes in children with hearing impairment. Existing literature focus mainly on subpopulations (children with hearing aids, children with CI) and is usually not epidemiological. Often children with additional needs (intellectual disability, visual impairment, autism spectrum disorder, complex syndromes) are excluded from the studies. This subgroup of children makes up around 1/3 of the population of children with hearing impairment.

What factors contribute to the unexplained variance in language development in children with hearing loss? (including children with additional needs, multilingual) There is a lack of European epidemiological studies that evaluate the effects of Newborn Hearing Screening and early intervention.

Study Overview

Detailed Description

Aims:

  • to collect population based data on children born in Upper Austria with a significant hearing impairment and to describe this population in detail regarding audiological, etiological (including geno- and phenotypical correlations), neurodevelopmentally, psychological, psychiatrically and linguistically with a special interest is in children with additional needs
  • collecting child development outcomes (language, communication, psychosocial) and family outcomes (quality of life, stress)
  • to investigate possible effects of the Newborn Hearing Screening, early intervention and specific parent behaviors targeted in early intervention
  • collecting developmental trajectories of the total sample and subgroups of the sample (particularly audiological, etiological and cognitive). This data should help identify red flags
  • investigating predictors of developmental trajectories regarding the child and the intervention (e.g. time and

Hypothesis:

  • It is expected that .2% of the total population of preschool children have a sensorineural hearing loss (bilateral and unilateral)
  • a significantly higher prevalence of intellectual disabilities (up to 20%), visual impairment, autism spectrum disorder and motor impairment
  • it is expected that for at least 50% of the children, there is a genetic explanation for the hearing impairment and 30% out of them are expected to be syndromal
  • it is expected that there is a higher proportion of children with psycho-social problems (especially peer problems and behavioral-/emotional problems)
  • Due to a change in the environmental conditions over the past two decades, better child outcomes, compared to previous ones are expected. Nevertheless around 30-50% of the children are expected to not be reaching their nonverbal cognitive potential.
  • expected intervention effects, particularly for provision with and use of hearing technology family-child interaction self-efficacy and wellbeing of the family regulated media use

Study Type

Observational

Enrollment (Anticipated)

450

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Linz, Austria, 4020
        • Recruiting
        • Johannes Kepler University
        • Contact:
        • Sub-Investigator:
          • Magdalena Dall

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 6 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All children in Upper Austria with a significant sensorineural hearing impairment or permanent congential conductive deafness who were diagnosed before the age of 6 years are included in the study.

Description

Inclusion Criteria:

  • with significant sensorineural hearing impairment or permanent congenital conductive deafness; profound hearing impairment above frequency of 0.5, 1, 2 and 4 kHz of ≥ 25 dB
  • unilateral or bilateral
  • diagnosed before the age of 6 years
  • including children with multiple disabilities
  • including children with another language than German (including sign language)
  • including children with auditory neuropathy spectrum disorder (ANS)
  • including children with behavioral problems and psychiatric disorders

Exclusion Criteria:

  • children who were older than 6 years when they were diagnosed
  • who's families do not agree to participate in the study
  • with temporary conductive deafness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vocabulary Expressive of the Child
Time Frame: 5 years

Questionnaire used for this Outcome is:

SET 3-5

5 years
Vocabulary Receptive of the Child
Time Frame: 5 years

Questionnaire used for this Outcome is:

PPVT-4

5 years
Grammar Expressive of the Child
Time Frame: 5 years

Questionnaire used for this Outcome is:

LOGIK_S Expressive Grammatik

5 years
Language Receptive of the Child
Time Frame: 5 years

Questionnaire used for this Outcome is:

TROG-D

5 years
Language Receptive of the Child (ÖGS)
Time Frame: 5 years

Questionnaire used for this Outcome is:

RDLS ÖGS

5 years
Social Communication of the Child
Time Frame: 5 years

Questionnaire used for this Outcome is:

CCC-2

5 years
Symbolic Behaviour of the Child
Time Frame: 5 years

Questionnaire used for this Outcomes is:

CSBS

5 years
Psychosocial Development of the Child
Time Frame: 5 years

Questionnaire used for this Outcome is:

SDQ

5 years
Emotional and Behaviour Problems of the Child
Time Frame: 5 years

Questionnaire used for this Outcome is:

CBCL

5 years
Quality of Life of the Child
Time Frame: 5 years

Questionnaire used for this Outcome is:

AUQUEI

5 years
Family Stress
Time Frame: 5 years

Questionnaire used for this Outcome is:

EBI (Elternbelastungsinventar)

5 years
Parental Self-Efficacy
Time Frame: 5 years

Questionnaire used for this Outcome is:

SPISE-R

5 years
Non-Verbal Development
Time Frame: 5 years

Questionnaire used for this Outcome is:

SON

5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Executive Functioning of the Child
Time Frame: 5 years

The questionnaire used for this Outcome is:

VIEF (Verhaltens - Inventar Exekutiver Funktionen)

5 years
Adaptive Skills of the Child
Time Frame: 5 years

The questionnaire used for this Outcome is:

Vineland-2

5 years
Visual successive memory and attention
Time Frame: 5 years

The questionnaire used for this Outcome is:

KNOX cube test

5 years
Phonological working memory
Time Frame: 5 years

The questionnaire used for this Outcome is:

Mottier test

5 years
Mental Health
Time Frame: 5 years

The questionnaire used for this Outcome is:

SDQ 4-16 (Strength and Difficulties Questionnaire)

5 years
Media use
Time Frame: 5 years

The questionnaire used for this Outcome is:

Kinder und Medien Fragebogen

5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2019

Primary Completion (Anticipated)

June 1, 2025

Study Completion (Anticipated)

August 1, 2025

Study Registration Dates

First Submitted

February 27, 2020

First Submitted That Met QC Criteria

March 19, 2020

First Posted (Actual)

March 23, 2020

Study Record Updates

Last Update Posted (Actual)

March 31, 2022

Last Update Submitted That Met QC Criteria

March 29, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hearing Impaired Children

Clinical Trials on Hearing Aids and Hearing Implants

3
Subscribe